Crossject Société Anonyme (ALCJ.PA)
EUR 2.0
(1.01%)
EUR 2.0
(1.01%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -11.8 Million EUR | -8.91% |
| 2022 | -13.22 Million EUR | -9.89% |
| 2021 | -12.03 Million EUR | -10.51% |
| 2020 | -10.89 Million EUR | -19.38% |
| 2019 | -9.12 Million EUR | 24.05% |
| 2018 | -12.01 Million EUR | -33.8% |
| 2017 | -8.97 Million EUR | -17.44% |
| 2016 | -7.64 Million EUR | -27.99% |
| 2015 | -5.97 Million EUR | -16.93% |
| 2014 | -5.1 Million EUR | -95.26% |
| 2013 | -2.61 Million EUR | -85.01% |
| 2012 | -1.41 Million EUR | 23.77% |
| 2011 | -1.85 Million EUR | 58.15% |
| 2010 | -4.43 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -6.71 Million EUR | 0.0% |
| 2023 Q2 | -8.31 Million EUR | 0.0% |
| 2023 FY | -14.4 Million EUR | -8.91% |
| 2023 Q4 | -5.26 Million EUR | 0.0% |
| 2022 FY | -13.22 Million EUR | -9.89% |
| 2022 Q2 | -7.01 Million EUR | 0.0% |
| 2022 Q4 | -6.21 Million EUR | 0.0% |
| 2021 Q4 | -5.7 Million EUR | 0.0% |
| 2021 FY | -12.03 Million EUR | -10.51% |
| 2021 Q2 | -6.32 Million EUR | 0.0% |
| 2020 Q2 | -5.66 Million EUR | 0.0% |
| 2020 Q4 | -5.23 Million EUR | 0.0% |
| 2020 FY | -10.89 Million EUR | -19.38% |
| 2019 Q4 | -3.26 Million EUR | 0.0% |
| 2019 FY | -9.12 Million EUR | 24.05% |
| 2019 Q2 | -5.85 Million EUR | 0.0% |
| 2018 Q2 | -3.84 Million EUR | 0.0% |
| 2018 FY | -12.01 Million EUR | -33.8% |
| 2018 Q4 | -7.71 Million EUR | 0.0% |
| 2017 FY | -8.97 Million EUR | -17.44% |
| 2017 Q4 | -4.36 Million EUR | 0.0% |
| 2017 Q2 | -4.25 Million EUR | 0.0% |
| 2016 Q4 | -4.51 Million EUR | 0.0% |
| 2016 Q2 | -2.77 Million EUR | 0.0% |
| 2016 FY | -7.64 Million EUR | -27.99% |
| 2015 Q4 | -3.24 Million EUR | 0.0% |
| 2015 Q2 | -3.76 Million EUR | 0.0% |
| 2015 FY | -5.97 Million EUR | -16.93% |
| 2014 Q2 | -2.38 Million EUR | 0.0% |
| 2014 FY | -5.1 Million EUR | -95.26% |
| 2014 Q4 | -2.71 Million EUR | 0.0% |
| 2013 Q1 | -548.82 Thousand EUR | 0.0% |
| 2013 FY | -2.61 Million EUR | -85.01% |
| 2013 Q4 | -1.65 Million EUR | -201.71% |
| 2013 Q3 | -548.82 Thousand EUR | 47.48% |
| 2013 Q2 | -1.04 Million EUR | -90.41% |
| 2012 FY | -1.41 Million EUR | 23.77% |
| 2012 Q1 | -349.1 Thousand EUR | 0.0% |
| 2012 Q2 | -349.1 Thousand EUR | 0.0% |
| 2012 Q3 | -349.1 Thousand EUR | 0.0% |
| 2012 Q4 | -548.82 Thousand EUR | -57.21% |
| 2011 Q4 | -349.1 Thousand EUR | -289.37% |
| 2011 FY | -1.85 Million EUR | 58.15% |
| 2011 Q3 | 184.35 Thousand EUR | 0.0% |
| 2011 Q2 | 184.35 Thousand EUR | 0.0% |
| 2011 Q1 | 184.35 Thousand EUR | 0.0% |
| 2010 Q1 | -1.3 Million EUR | 0.0% |
| 2010 Q4 | 184.35 Thousand EUR | 114.09% |
| 2010 Q3 | -1.3 Million EUR | 0.0% |
| 2010 FY | -4.43 Million EUR | 0.0% |
| 2010 Q2 | -1.3 Million EUR | 0.0% |
| 2009 Q4 | -1.3 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Safe Orthopaedics SA | -5.96 Million EUR | -97.92% |
| Spineway SA | -9.03 Million EUR | -30.618% |
| Amplitude Surgical SA | 13.24 Million EUR | 189.117% |
| Sartorius Stedim Biotech S.A. | 484.5 Million EUR | 102.436% |
| EssilorLuxottica Société anonyme | 3.17 Billion EUR | 100.372% |
| bonyf N.V. | -39.89 Thousand EUR | -29478.316% |